Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management.

COVID-19 Coronavirus SARS-CoV-2 pandemic zoonosis

Journal

International journal of general medicine
ISSN: 1178-7074
Titre abrégé: Int J Gen Med
Pays: New Zealand
ID NLM: 101515487

Informations de publication

Date de publication:
2023
Historique:
received: 21 05 2023
accepted: 19 08 2023
medline: 27 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

The re-emergence of COVID-19 has sparked controversy around its zoonotic origin, management strategies, risks posed by the virus, and the severity of reinfection. While it is widely accepted that the virus originated from animals, the exact source and transmission pathway remain unclear. This has led to debates regarding the regulation of wildlife markets and trade, as well as the need for more robust surveillance and monitoring systems. Hence, the objective of this review is to provide a brief overview of the disease's biology, preventative strategies, risk factors, degree of reinfection, and epidemiological profile. It offers a thorough examination of the disease's root cause, potential zoonotic transmission, and the most recent preventive measures, like vaccines. In terms of management, there is ongoing debate about the most effective strategies to mitigate the spread of the virus. While public health measures such as social distancing and mask-wearing have been widely implemented, there are differing opinions on the effectiveness of lockdowns and restrictions on public movement. The risks posed by COVID-19 are also a topic of debate, with some arguing that the virus is relatively low-risk for the majority of the population while others highlight the potential for severe illness, particularly among vulnerable populations such as the elderly or those with underlying health conditions. Finally, the possibility of reinfection has raised concerns about the longevity of immunity following infection or vaccination. While some studies have suggested that reinfection may be possible and potentially more severe, the overall risk remains uncertain and further research is needed to fully understand the implications of reinfection.

Identifiants

pubmed: 37753439
doi: 10.2147/IJGM.S419789
pii: 419789
pmc: PMC10518360
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

4307-4319

Informations de copyright

© 2023 Chala et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Environ Res. 2022 Aug;211:113038
pubmed: 35231456
Pharmacol Res. 2020 Jul;157:104872
pubmed: 32360583
J Chemother. 2021 Apr;33(2):67-84
pubmed: 33427110
Clin Immunol. 2020 May;214:108393
pubmed: 32222466
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Cureus. 2020 Mar 21;12(3):e7355
pubmed: 32328367
N Engl J Med. 2020 Aug 6;383(6):590-592
pubmed: 32402155
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
Clin Infect Dis. 2021 May 18;72(10):e652-e654
pubmed: 32857833
J Med Virol. 2020 Apr;92(4):455-459
pubmed: 31994738
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Viruses. 2022 Jan 02;14(1):
pubmed: 35062282
Build Environ. 2022 Aug 1;221:109328
pubmed: 35784591
Emerg Infect Dis. 2004 Feb;10(2):320-6
pubmed: 15030705
Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6
pubmed: 15616839
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Front Public Health. 2021 Jan 08;8:599769
pubmed: 33490020
Microorganisms. 2020 Sep 12;8(9):
pubmed: 32932606
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Feb 29;395(10225):683-684
pubmed: 32122468
J Proteome Res. 2020 Dec 4;19(12):4844-4856
pubmed: 33175551
Vet Res Commun. 2021 Feb;45(1):1-19
pubmed: 33464439
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Genome Biol Evol. 2022 Feb 4;14(2):
pubmed: 35137080
NPJ Vaccines. 2021 Nov 29;6(1):142
pubmed: 34845231
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
NPJ Vaccines. 2021 Feb 22;6(1):28
pubmed: 33619260
Ann Intern Med. 2021 Jul;174(7):1037
pubmed: 34280346
New Microbes New Infect. 2020 Nov;38:100778
pubmed: 33042554
Vet Q. 2021 Dec;41(1):181-201
pubmed: 33892621
Environ Chem Lett. 2021;19(1):5-16
pubmed: 33024427
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
J Virol. 2016 Jul 27;90(16):7415-7428
pubmed: 27279608
Viruses. 2021 Sep 16;13(9):
pubmed: 34578428
Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S223-7, discussion S226
pubmed: 16378050
Rev Med Virol. 2022 Sep;32(5):e2346
pubmed: 35416390
Biol Rev Camb Philos Soc. 2021 Dec;96(6):2694-2715
pubmed: 34231315
Biomol NMR Assign. 2021 Oct;15(2):287-295
pubmed: 33770349
Mol Biol Rep. 2022 Jun;49(6):4943-4957
pubmed: 35235159
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Infez Med. 2021 Mar 1;29(1):10-19
pubmed: 33664169
Science. 2020 Jul 17;369(6501):315-319
pubmed: 32423996
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Adv Exp Med Biol. 2006;581:163-73
pubmed: 17037525
J Clin Invest. 2021 Apr 1;131(7):
pubmed: 33621214
Infection. 2021 Apr;49(2):199-213
pubmed: 32886331
Int J Infect Dis. 2020 May;94:133-138
pubmed: 32247826
Emerg Microbes Infect. 2022 Dec;11(1):1103-1114
pubmed: 35333692
Nat Rev Immunol. 2021 Apr;21(4):245-256
pubmed: 33723416
Lancet. 2020 Apr 4;395(10230):1137-1144
pubmed: 32178768
Expert Rev Vaccines. 2021 Apr;20(4):365-373
pubmed: 33851875
Psychiatry Res. 2020 Jun;288:112945
pubmed: 32302813
J Clin Med. 2021 Jun 07;10(11):
pubmed: 34200502
Trends Microbiol. 2020 Nov;28(11):900-912
pubmed: 32448762
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
Int J Surg. 2020 May;77:206-216
pubmed: 32289472
Front Med (Lausanne). 2021 Jan 14;7:594439
pubmed: 33585502
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Vaccines (Basel). 2018 Apr 01;6(2):
pubmed: 29614788
Lancet Reg Health Eur. 2022 Sep;20:100453
pubmed: 35791336
JAMA. 2020 Aug 4;324(5):441-442
pubmed: 32749495
SSM Popul Health. 2021 Feb 13;13:100751
pubmed: 33665333
Vaccines (Basel). 2022 Mar 30;10(4):
pubmed: 35455285
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
Prog Cardiovasc Dis. 2022 Mar-Apr;71:4-10
pubmed: 35490870
J Hosp Infect. 2016 Mar;92(3):235-50
pubmed: 26597631
Trends Microbiol. 2013 Oct;21(10):544-55
pubmed: 23770275
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
Arch Bronconeumol. 2022 Apr;58 Suppl 1:39-50
pubmed: 35501222
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
SN Compr Clin Med. 2021;3(3):790-792
pubmed: 33623865
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
J Neuroimmune Pharmacol. 2020 Sep;15(3):359-386
pubmed: 32696264
Clin Infect Dis. 2021 Jul 30;73(Suppl 2):S170-S176
pubmed: 32964919
Lancet Respir Med. 2021 Dec;9(12):1450-1466
pubmed: 34688434
Nature. 2021 Jul;595(7868):572-577
pubmed: 34044428
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Vaccine. 2021 Jan 15;39(3):457-459
pubmed: 33339671
Immunity. 2020 Apr 14;52(4):583-589
pubmed: 32259480
Cell Host Microbe. 2021 Jul 14;29(7):1137-1150.e6
pubmed: 34133950

Auteurs

Bayissa Chala (B)

Department of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama, Ethiopia.

Tigist Tilaye (T)

Olanchiti Hospital, Oromia Health Bureau, Oromia Regional State, Ethiopia.

Gemechis Waktole (G)

Department of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama, Ethiopia.
Department of Biotechnology, College of Natural and Computational Science, Dambi Dollo University, Dambi Dollo, Ethiopia.

Classifications MeSH